This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0630U only for BluePrint® Molecular Subtyping Test from Agendia® Inc. This oncology test for breast cancer uses messenger ribonucleic acid (mRNA) gene expression profiling by microarray to evaluate 80 genes, using formalin–fixed paraffin–embedded tissue (FFPE). The test uses an algorithm to report an index that is diagnostic of a molecular subtype, such as luminal, basal, or HER2.
For clinical responsibility, terminology, tips and additional info
start codify free trial.